NO862676L - Analogifremgangsmaate ved fremstilling av terapeutisk virksomme benzamider. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk virksomme benzamider.

Info

Publication number
NO862676L
NO862676L NO862676A NO862676A NO862676L NO 862676 L NO862676 L NO 862676L NO 862676 A NO862676 A NO 862676A NO 862676 A NO862676 A NO 862676A NO 862676 L NO862676 L NO 862676L
Authority
NO
Norway
Prior art keywords
benzamides
preparation
therapeutically effective
analogy procedure
analogy
Prior art date
Application number
NO862676A
Other languages
English (en)
Other versions
NO862676D0 (no
NO166124B (no
NO166124C (no
Inventor
Jacqueline Franceschini
Renee Gardaix-Luthereau
Josette Margarit
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of NO862676D0 publication Critical patent/NO862676D0/no
Publication of NO862676L publication Critical patent/NO862676L/no
Priority to NO872326A priority Critical patent/NO168472C/no
Publication of NO166124B publication Critical patent/NO166124B/no
Publication of NO166124C publication Critical patent/NO166124C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
NO862676A 1985-07-04 1986-07-02 Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzamidforbindelser. NO166124C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO872326A NO168472C (no) 1985-07-04 1987-06-03 Substituerte cyanomethylbenzamidforbindelser egnet for anvendelse som mellomprodukter ved fremstilling av terapeutisk virksomme benzamidforbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8510199A FR2584401B1 (fr) 1985-07-04 1985-07-04 Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique

Publications (4)

Publication Number Publication Date
NO862676D0 NO862676D0 (no) 1986-07-02
NO862676L true NO862676L (no) 1987-01-05
NO166124B NO166124B (no) 1991-02-25
NO166124C NO166124C (no) 1991-06-12

Family

ID=9320954

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862676A NO166124C (no) 1985-07-04 1986-07-02 Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzamidforbindelser.

Country Status (42)

Country Link
US (1) US4703055A (no)
EP (1) EP0210893B1 (no)
JP (1) JPS62103069A (no)
KR (1) KR920007271B1 (no)
CN (1) CN1021441C (no)
AR (1) AR241906A1 (no)
AT (1) ATE57181T1 (no)
AU (1) AU582253B2 (no)
BE (1) BE905018A (no)
BG (1) BG45853A3 (no)
CA (2) CA1276644C (no)
CH (1) CH667873A5 (no)
CS (1) CS274658B2 (no)
DD (1) DD251554A5 (no)
DE (2) DE3620215A1 (no)
DK (2) DK316386A (no)
EG (1) EG18057A (no)
ES (1) ES2000187A6 (no)
FI (1) FI86422C (no)
FR (1) FR2584401B1 (no)
GB (1) GB2178035B (no)
GR (1) GR861714B (no)
HU (1) HU198023B (no)
IE (1) IE58577B1 (no)
IL (1) IL79241A (no)
IN (1) IN163430B (no)
IS (1) IS1374B6 (no)
IT (1) IT1214686B (no)
LU (1) LU86499A1 (no)
MA (1) MA20725A1 (no)
NO (1) NO166124C (no)
NZ (1) NZ216704A (no)
OA (1) OA08355A (no)
PH (2) PH23435A (no)
PL (1) PL147410B1 (no)
PT (1) PT82853B (no)
SU (1) SU1605924A3 (no)
TN (1) TNSN86099A1 (no)
YU (1) YU44790B (no)
ZA (1) ZA864874B (no)
ZM (1) ZM5086A1 (no)
ZW (1) ZW12286A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2057324A1 (en) * 1990-12-18 1992-06-19 Lora Louise Fitch Benzamide and sulfonamide hypoglycemic agents
US5214189A (en) * 1992-06-15 1993-05-25 The United States Of America As Represented By The Secretary Of The Navy N-(2-hydroxyethyl nitrate)-2,4,6,-trinitrobenzamide
US7507727B2 (en) * 2003-04-07 2009-03-24 Cylene Pharmaceuticals, Inc. Substituted quinobenzoxazine analogs and methods of using thereof
NZ590570A (en) * 2005-03-14 2012-06-29 Janssen Pharmaceutica Nv Process for the preparation of opioid modulators

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2376424A (en) * 1940-12-23 1945-05-22 Parke Davis & Co Biological product and process of obtaining same
GB1268259A (en) * 1969-11-18 1972-03-29 Beecham Group Ltd Imidazoline derivatives
AT311338B (de) * 1971-03-08 1973-11-12 Malesci Sas Verfahren zum Herstellen eines neuen Imidazolinderivates und seiner Salze
CA1008856A (en) * 1971-11-15 1977-04-19 Ciba-Geigy Ag Triazolo-benzodiazepines
US3885040A (en) * 1973-02-28 1975-05-20 Univ Toledo Methods and benzamide compositions for producing hypotensive activity
GB1513631A (en) * 1976-02-17 1978-06-07 Gallardo Antonio Sa Piperidine derivatives
DK189677A (da) * 1976-05-07 1977-11-08 Sumitomo Chemical Co M-phenoxybenzamid-derivater
FR2415099A1 (fr) * 1978-01-20 1979-08-17 Ile De France Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Also Published As

Publication number Publication date
CA1276644C (fr) 1990-11-20
US4703055A (en) 1987-10-27
HUT42451A (en) 1987-07-28
IL79241A0 (en) 1986-09-30
PH23435A (en) 1989-08-07
CS274658B2 (en) 1991-09-15
LU86499A1 (fr) 1986-12-02
DE3620215A1 (de) 1987-01-08
DE3674667D1 (de) 1990-11-08
EP0210893A1 (fr) 1987-02-04
IS1374B6 (is) 1989-06-30
NO862676D0 (no) 1986-07-02
FI86422B (fi) 1992-05-15
FR2584401A1 (fr) 1987-01-09
NO166124B (no) 1991-02-25
EG18057A (en) 1991-08-30
EP0210893B1 (fr) 1990-10-03
IE58577B1 (en) 1993-10-06
DD251554A5 (de) 1987-11-18
FR2584401B1 (fr) 1987-11-20
PH25219A (en) 1991-03-27
CN1021441C (zh) 1993-06-30
DK316386A (da) 1987-01-05
OA08355A (fr) 1988-02-29
ATE57181T1 (de) 1990-10-15
DK316386D0 (da) 1986-07-03
FI86422C (fi) 1992-08-25
DK204891D0 (da) 1991-12-20
GR861714B (en) 1986-11-04
MA20725A1 (fr) 1987-04-01
KR870001172A (ko) 1987-03-11
CH667873A5 (fr) 1988-11-15
JPS62103069A (ja) 1987-05-13
GB2178035B (en) 1989-02-08
PL147410B1 (en) 1989-05-31
IL79241A (en) 1990-04-29
YU44790B (en) 1991-02-28
CA1300162C (fr) 1992-05-05
ZW12286A1 (en) 1986-11-05
PT82853A (fr) 1986-07-01
DK204891A (da) 1991-12-20
AU582253B2 (en) 1989-03-16
NZ216704A (en) 1990-03-27
IT1214686B (it) 1990-01-18
CS504086A2 (en) 1990-09-12
JPH0586942B2 (no) 1993-12-14
YU115086A (en) 1988-02-29
IE861796L (en) 1987-01-04
TNSN86099A1 (fr) 1990-01-01
GB2178035A (en) 1987-02-04
GB8616287D0 (en) 1986-08-13
IN163430B (no) 1988-09-17
PT82853B (pt) 1988-04-21
ES2000187A6 (es) 1988-01-01
FI862793A (fi) 1987-01-05
IS3116A7 (is) 1987-01-05
NO166124C (no) 1991-06-12
KR920007271B1 (ko) 1992-08-29
BE905018A (fr) 1987-01-02
BG45853A3 (en) 1989-08-15
CN86105682A (zh) 1987-02-04
AR241906A1 (es) 1993-01-29
IT8648189A0 (it) 1986-06-27
ZM5086A1 (en) 1986-11-28
ZA864874B (en) 1987-02-25
SU1605924A3 (ru) 1990-11-07
AU5977986A (en) 1987-01-08
HU198023B (en) 1989-07-28
FI862793A0 (fi) 1986-07-01

Similar Documents

Publication Publication Date Title
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO862924L (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme substituerte di-tert.-butylfenoler.
NO863574L (no) Fremgangsmaate ved fremstilling av tetrafluorbenzosyre.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO168706C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-heterosyklisk substituerte benzamider.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO168105C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridinsubstituerte oxazoloner
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO860794L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO164415C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.
NO862676L (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme benzamider.
NO865148D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider.
NO165538C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO864386L (no) Fremgangsmaate ved fremstilling av uretaner.
NO168581C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-thiofenethanaminer
NO172386C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
NO159444C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetylamin-derivater.
NO160513C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner.
NO156751B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive p-oxooxazolidinylbenzensulfonamider.